Certified by Founder Lodge
Northpond Ventures
United States - Bethesda, Maryland
INVESTOR
1 Disclosed Funding Rounds $100,000,000
26 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Northpond Ventures is a multi-billion dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has been named one of the three most ac
| Company | Date | Round | Raised |
|---|---|---|---|
Kyverna Therapeutics |
August, 03 ,2023 | Series B | $60,000,000 |
CAMP4 Therapeutics |
July, 20 ,2022 | Series B | $100,000,000 |
Aro Biotherapeutics |
November, 29 ,2023 | Series B | $41,500,000 |
Delfi Diagnostics |
July, 18 ,2022 | Series B | $225,000,000 |
Molecule |
July, 01 ,2022 | Seed | $12,700,000 |
Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
DNAnexus |
June, 09 ,2022 | Unknown | $100,000,000 |
Inflammatix, Inc. |
September, 13 ,2024 | Series E | $57,000,000 |
Faro Health Inc. |
February, 16 ,2023 | Unknown | $20,000,000 |
VieCure |
October, 02 ,2024 | Unknown | $45,000,000 |
Triumvira Immunologics, Inc. |
March, 17 ,2022 | Series A | $100,000,000 |
Selux Diagnostics, Inc |
March, 01 ,2022 | Series C | $50,000,000 |
Eleanor Health |
October, 08 ,2024 | Series D | $30,000,000 |
Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
EnPlusOne Biosciences |
February, 21 ,2025 | Unknown | $10,000,000 |
Kyverna Therapeutics |
August, 03 ,2023 | Series B | $60,000,000 |
QbDVision |
May, 02 ,2025 | Unknown | $13,000,000 |
Aro Biotherapeutics |
November, 29 ,2023 | Series B | $41,500,000 |
Outcomes4Me |
May, 30 ,2025 | Unknown | $21,000,000 |
Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
Inflammatix, Inc. |
September, 13 ,2024 | Series E | $57,000,000 |
VieCure |
October, 02 ,2024 | Unknown | $45,000,000 |
Eleanor Health |
October, 08 ,2024 | Series D | $30,000,000 |
EnPlusOne Biosciences |
February, 21 ,2025 | Unknown | $10,000,000 |
QbDVision |
May, 02 ,2025 | Unknown | $13,000,000 |
Outcomes4Me |
May, 30 ,2025 | Unknown | $21,000,000 |
Kyverna Therapeutics
CAMP4 Therapeutics
Aro Biotherapeutics
Delfi Diagnostics
Molecule
Elephas
DNAnexus
Inflammatix, Inc.
Faro Health Inc.
VieCure
Triumvira Immunologics, Inc.
Selux Diagnostics, Inc
Eleanor Health
Octave (US)
EnPlusOne Biosciences
QbDVision
Outcomes4Me
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Honey Health | $7,800,000 | (Oct 28, 2025)
WorkHero | $5,000,000 | (Oct 28, 2025)
PodPlay Technologies | $8,000,000 | (Oct 28, 2025)
Seneca | $60,000,000 | (Oct 28, 2025)
Natural | $9,800,000 | (Oct 28, 2025)